ARIA is the most common side effect of anti–amyloid-beta MAB treatment. MABs increase vascular permeability, which can result in inflammation and leakage of proteinaceous fluid and blood products, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results